Production (Stage)
Atossa Therapeutics, Inc.
ATOS
$0.8317
-$0.0382-4.39%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -26.34M | -25.50M | -26.91M | -25.91M | -29.69M |
| Total Depreciation and Amortization | 16.00K | 17.00K | 27.00K | 26.00K | 25.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.15M | 4.01M | 3.75M | 2.22M | 6.46M |
| Change in Net Operating Assets | -116.00K | 448.00K | 3.58M | 4.98M | 4.59M |
| Cash from Operations | -22.29M | -21.03M | -19.55M | -18.68M | -18.62M |
| Capital Expenditure | -22.00K | -19.00K | -19.00K | -10.00K | -20.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -22.00K | -19.00K | -19.00K | -10.00K | -20.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.47M | 3.67M | 304.00K | 304.00K | 204.00K |
| Repurchase of Common Stock | -- | -- | 0.00 | -1.48M | -1.48M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3.47M | 3.67M | 304.00K | -1.17M | -1.27M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -18.84M | -17.38M | -19.27M | -19.86M | -19.91M |